Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy M Goodwin

Showing results (241-250 of 258) with videos related to

Pageof 26
Sort By:
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 2019
Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUMDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2021
Corrigendum to "Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121-136]"Mirko Manchia, Eduard Vieta, Olav B Smeland, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2021
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders networkLars Vedel Kessing, Ana González-Pinto, Andrea Fagiolini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Journal of Affective Disorders|December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders|October 11, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Molecular Psychiatry|June 15, 2023
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depressionSameer Jauhar, Danilo Arnone, David S Baldwin, et al.
The Lancet. Psychiatry|September 11, 2017
The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysisDaniel Freeman, Bryony Sheaves, Guy M Goodwin, et al.
Journal of Affective Disorders|February 5, 2023
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Pageof 26

Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
The British Journal of Psychiatry : the Journal of Mental Science|March 1, 2019
Treatment-resistant and Multi-therapy resistant criteria for bipolar depression: consensus definition - CORRIGENDUMDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
The British Journal of Psychiatry : the Journal of Mental Science|December 7, 2018
Treatment-resistant and multi-therapy-resistant criteria for bipolar depression: consensus definitionDiego Hidalgo-Mazzei, Michael Berk, Andrea Cipriani, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 26, 2021
Corrigendum to "Translating big data to better treatment in bipolar disorder - a manifesto for coordinated action [European Neuropsychopharmacology (2020) 36, 121-136]"Mirko Manchia, Eduard Vieta, Olav B Smeland, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 5, 2021
DSM-5 and ICD-11 criteria for bipolar disorder: Implications for the prevalence of bipolar disorder and validity of the diagnosis - A narrative review from the ECNP bipolar disorders networkLars Vedel Kessing, Ana González-Pinto, Andrea Fagiolini, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 16, 2020
Translating big data to better treatment in bipolar disorder - a manifesto for coordinated actionMirko Manchia, Eduard Vieta, Olav B Smeland, et al.
Journal of Affective Disorders|December 20, 2024
The role of the psychedelic experience in psilocybin treatment for treatment-resistant depressionGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Journal of Affective Disorders|October 11, 2025
Corrigendum to "The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression" [Journal of Affective Disorders, Volume 372 (2025), Pages 523-532]Guy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Molecular Psychiatry|June 15, 2023
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depressionSameer Jauhar, Danilo Arnone, David S Baldwin, et al.
The Lancet. Psychiatry|September 11, 2017
The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysisDaniel Freeman, Bryony Sheaves, Guy M Goodwin, et al.
Journal of Affective Disorders|February 5, 2023
Single-dose psilocybin for a treatment-resistant episode of major depression: Impact on patient-reported depression severity, anxiety, function, and quality of lifeGuy M Goodwin, Scott T Aaronson, Oscar Alvarez, et al.
Pageof 26